Financials

Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

新闻